FDA Inspection 700681 — Midwest Center For Reproductive Health
The FDA completed an inspection of Midwest Center For Reproductive Health on Dec 7, 2010 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 7, 2010
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maple Grove, MN (United States)